High Tower Advisors, LLC Gritstone Bio, Inc. Transaction History

High Tower Advisors, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$1.96 - $2.9 $17,150 - $25,375	8,750 Added 33.02%	35,250 $90,000
Q4 2023 Feb 12, 2024	SELL	$1.28 - $2.85 $25,395 - $56,544	-19,840 Reduced 42.81%	26,500 $54,000
Q3 2023 Nov 08, 2023	BUY	$1.19 - $2.26 $4,760 - $9,040	4,000 Added 9.45%	46,340 $79,000
Q2 2023 Aug 14, 2023	BUY	$1.66 - $3.03 $24,900 - $45,450	15,000 Added 54.86%	42,340 $82,000
Q1 2023 May 11, 2023	SELL	$2.13 - $3.74 $2,130 - $3,740	-1,000 Reduced 3.53%	27,340 $76,000
Q4 2022 Feb 08, 2023	BUY	$2.17 - $3.92 $4,340 - $7,840	2,000 Added 7.59%	28,340 $97,000
Q3 2022 Nov 09, 2022	BUY	$2.46 - $4.75 $3,690 - $7,125	1,500 Added 6.04%	26,340 $67,000
Q1 2022 May 12, 2022	BUY	$4.03 - $12.19 $18,130 - $54,842	4,499 Added 22.12%	24,840 $102,000
Q4 2021 Feb 10, 2022	SELL	$8.76 - $13.71 $108,177 - $169,304	-12,349 Reduced 37.78%	20,341 $262,000
Q3 2021 Nov 12, 2021	SELL	$6.41 - $13.54 $18,909 - $39,943	-2,950 Reduced 8.28%	32,690 $352,000
Q2 2021 Aug 06, 2021	BUY	$8.13 - $10.2 $18,211 - $22,848	2,240 Added 6.71%	35,640 $325,000
Q1 2021 May 10, 2021	BUY	$4.07 - $27.11 $40,293 - $268,389	9,900 Added 42.13%	33,400 $315,000
Q4 2020 Feb 10, 2021	BUY	$2.57 - $4.22 $11,565 - $18,990	4,500 Added 23.68%	23,500 $93,000
Q3 2020 Nov 13, 2020	BUY	$2.63 - $8.09 $49,970 - $153,710	19,000 New	19,000 $50,000

35.4M

395K

132K

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.